This research uncovers binding mechanisms at orexin 2 receptors, implying improved therapeutic design for sleep disorders.
A detailed understanding of ligand recognition and binding at the orexin receptor 2 (OXR2) is essential for the rational design of selective therapeutics for sleep and neuropsychiatric disorders.
No takes yet. Share an insight, caveat, or question.
Sena et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: